Financial Ratios Abbisko Cayman Limited

Equities

2256

KYG0028A1085

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 09:09:05 15/05/2026 BST			5-day change	1st Jan Change
10.77 ^HKD	-2.97%		-7.95%	-17.22%

04-29	Abbisko Completes HK$523 Million Share Offering	MT
04-23	Abbisko Therapeutics Showcases Six Research Advances Highlighting Pan-KRAS, 4th Generation EGFR, And Synthetic Lethality Approaches	CI

c00bf96b825756f21c8a7e.1cUS2zDWig6H1TPt60PMFih09l9QGWDQOEUDApQ8E_M.4qlIjh2X50uyrwaKxgSrRm1CxS8WYBPpb3AzZqN6Yoat8VatA-DARu2bWA

Published financial data: ABBISKO CAYMAN LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	22.68M	-	19.06M	504M	612M
Other Revenues, Total	-	-	-	-	-
Total Revenues	22.68M	-	19.06M	504M	612M
Gross Profit	22.68M	-	19.06M	504M	612M
Selling General & Admin Expenses, Total	125M	118M	96.4M	74.21M	75.77M
R&D Expenses	226M	379M	434M	451M	508M
Other Operating Expenses, Total	351M	497M	530M	526M	584M
Operating Income	-328M	-497M	-511M	-21.59M	27.9M
Interest Expense, Total	-959K	-2.68M	-2.17M	-1.61M	-3.33M
Interest And Investment Income	16.94M	-	65.49M	89.1M	92.92M
Net Interest Expenses	15.98M	-2.68M	63.32M	87.49M	89.58M
Currency Exchange Gains (Loss)	6.67M	-41.3M	-5.6M	1.8M	-17.29M
Other Non Operating Income (Expenses)	14M	45.56M	21.07M	10.34M	14.24M
EBT, Excl. Unusual Items	-292M	-496M	-432M	78.03M	114M
Gain (Loss) On Sale Of Investments	5.9M	-	706K	-	2.03M
Other Unusual Items	-1.52B	-	-	-	-
EBT, Incl. Unusual Items	-1.81B	-496M	-432M	78.03M	116M
Income Tax Expense	-	-	-	49.73M	61.21M
Earnings From Continuing Operations	-1.81B	-496M	-432M	28.3M	55.25M
Net Income to Company	-1.81B	-496M	-432M	28.3M	55.25M
Net Income - (IS)	-1.81B	-496M	-432M	28.3M	55.25M
Net Income to Common Incl Extra Items	-1.81B	-496M	-432M	28.3M	55.25M
Net Income to Common Excl. Extra Items	-1.81B	-496M	-432M	28.3M	55.25M
Per Share Items
Net EPS - Basic	-7.71	-0.8	-0.67	0.04	0.09
Basic EPS - Continuing Operations	-7.71	-0.8	-0.67	0.04	0.09
Basic Weighted Average Shares Outstanding	235M	621M	647M	634M	625M
Net EPS - Diluted	-7.71	-0.8	-0.67	0.04	0.09
Diluted EPS - Continuing Operations	-7.71	-0.8	-0.67	0.04	0.09
Diluted Weighted Average Shares Outstanding	235M	621M	647M	650M	640M
Normalized Basic EPS	-0.78	-0.5	-0.42	0.08	0.11
Normalized Diluted EPS	-0.78	-0.5	-0.42	0.08	0.11
Supplemental Items
EBITDA	-323M	-493M	-505M	-10.79M	38.42M
EBITA	-328M	-497M	-511M	-21.59M	27.9M
EBIT	-328M	-497M	-511M	-21.59M	27.9M
EBITDAR	-	-491M	-504M	-10.02M	38.61M
Effective Tax Rate - (Ratio)	-	-	-	63.73	52.56
Current Foreign Taxes	-	-	-	49.73M	61.21M
Total Current Taxes	-	-	-	49.73M	61.21M
Normalized Net Income	-182M	-310M	-270M	48.77M	71.52M
Interest on Long-Term Debt	959K	2.68M	2.17M	1.61M	851K
Supplemental Operating Expense Items
General and Administrative Expenses	125M	118M	96.4M	74.21M	75.77M
Research And Development Expense From Footnotes	226M	379M	434M	451M	508M
Net Rental Expense, Total	-	1.35M	725K	770K	184K
Imputed Operating Lease Interest Expense	-	584K	310K	330K	29.94K
Imputed Operating Lease Depreciation	-	767K	415K	440K	154K
Stock-Based Comp., R&D Exp. (Total)	49.81M	65.11M	27.81M	13.77M	21.2M
Stock-Based Comp., G&A Exp. (Total)	40.12M	45.01M	19.59M	6.97M	11.4M
Stock-Based Comp., Other (Total)	429K	-	-	-	-
Total Stock-Based Compensation	90.36M	110M	47.4M	20.74M	32.61M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.55B	2.26B	1.97B	290M	749M
Short Term Investments	26.48M	26.05M	38.32M	1.72B	1.28B
Trading Asset Securities, Total	-	93.8M	918K	233K	72.51M
Total Cash And Short Term Investments	2.57B	2.38B	2.01B	2.01B	2.1B
Other Receivables	-	7.74M	-	-	14.99M
Notes Receivable	-	10.06M	9.38M	3.7M	-
Total Receivables	-	17.8M	9.38M	3.7M	14.99M
Other Current Assets, Total	9.39M	11.25M	21.29M	9.05M	12.76M
Total Current Assets	2.58B	2.41B	2.04B	2.02B	2.13B
Gross Property Plant And Equipment	83.24M	95.82M	98.16M	88.16M	77.9M
Accumulated Depreciation	-13.95M	-18.52M	-28.82M	-35.34M	-45.58M
Net Property Plant And Equipment	69.29M	77.3M	69.35M	52.82M	32.32M
Long-term Investments	-	-	-	-	142M
Other Intangibles, Total	3.05M	4.5M	4.63M	4.83M	4.2M
Other Long-Term Assets, Total	805K	27K	-	28.97M	47.6M
Total Assets	2.65B	2.49B	2.12B	2.11B	2.35B
Liabilities
Accrued Expenses, Total	22.3M	23.2M	81.65M	93.74M	109M
Short-term Borrowings	-	-	-	-	292M
Current Portion of Leases	8.86M	9.97M	10.61M	11.02M	8.63M
Current Income Taxes Payable	1.3M	24.05M	2.11M	16.14M	3.53M
Other Current Liabilities	41.08M	50.34M	14.79M	14.55M	14.44M
Total Current Liabilities	73.54M	108M	109M	135M	427M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	44.94M	35.61M	25.11M	13.27M	3.15M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	118M	143M	134M	149M	430M
Common Stock, Total	46K	46K	46K	44K	44K
Additional Paid In Capital	5.37B	5.5B	5.49B	5.49B	5.42B
Retained Earnings	-2.98B	-3.48B	-3.91B	-3.88B	-3.82B
Treasury Stock	-5K	-3K	-4K	-3K	-3K
Comprehensive Income and Other	146M	323M	395M	347M	328M
Total Common Equity	2.54B	2.35B	1.98B	1.96B	1.92B
Total Equity	2.54B	2.35B	1.98B	1.96B	1.92B
Total Liabilities And Equity	2.65B	2.49B	2.12B	2.11B	2.35B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	695M	647M	647M	629M	672M
ECS Total Common Shares Outstanding	695M	647M	647M	629M	672M
Book Value / Share	3.65	3.62	3.06	3.11	2.86
Tangible Book Value	2.53B	2.34B	1.98B	1.95B	1.92B
Tangible Book Value Per Share	3.64	3.62	3.05	3.11	2.85
Total Debt	53.8M	45.58M	35.72M	24.29M	303M
Net Debt	-2.52B	-2.33B	-1.98B	-1.98B	-1.8B
Debt Equivalent Oper. Leases	-	10.81M	5.8M	6.16M	1.47M
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	25.41M	33.27M	45.33M	47.61M	48.73M
Full Time Employees	160	250	258	281	-

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-1.81B	-496M	-432M	28.3M	55.25M
Depreciation & Amortization - CF	11.18M	14.12M	15.76M	20.44M	19.54M
Amortization of Goodwill and Intangible Assets - (CF)	704K	-	-	-	-
Depreciation & Amortization, Total	11.89M	14.12M	15.76M	20.44M	19.54M
Amortization of Deferred Charges, Total - (CF)	29.2M	1.67M	2.66M	3.13M	2.79M
(Gain) Loss From Sale Of Asset	-	-	59K	28K	38K
(Gain) Loss on Sale of Investments - (CF)	-	219K	-1.14M	692K	-2.03M
Stock-Based Compensation (CF)	90.36M	110M	47.4M	20.74M	32.61M
Other Operating Activities, Total	1.5B	8.67M	-57.28M	-93.85M	-18.37M
Change In Accounts Payable	28.31M	18.82M	1.72M	2.5M	4.25M
Change in Other Net Operating Assets	-21.18M	-1.92M	-22.32M	5.1M	-14.78M
Cash from Operations	-170M	-344M	-445M	-12.92M	79.29M
Capital Expenditure	-9.01M	-19.62M	-9.6M	-4.07M	-3.37M
Sale (Purchase) of Intangible assets	-3.32M	-3.13M	-2.65M	-3.33M	-2.16M
Investment in Marketable and Equity Securities, Total	-1.48B	-214M	345M	-248M	161M
Other Investing Activities, Total	28.81M	20.32M	46.14M	59.36M	56.91M
Cash from Investing	-1.46B	-217M	379M	-197M	212M
Short Term Debt Issued, Total	-	-	-	-	292M
Total Debt Issued	-	-	-	-	292M
Long-Term Debt Repaid, Total	-7.41M	-8.64M	-9.44M	-9.46M	-10.13M
Total Debt Repaid	-7.41M	-8.64M	-9.44M	-9.46M	-10.13M
Issuance of Common Stock	1.45B	3.74M	8.42M	6.53M	4.81M
Repurchase of Common Stock	-	-4.06M	-12.91M	-76.32M	-96.15M
Issuance of Preferred Stock	777M	-	-	-	-
Other Financing Activities, Total	-119M	-11.86M	-2.17M	-1.61M	-3.14M
Cash from Financing	2.1B	-20.81M	-16.1M	-80.86M	187M
Foreign Exchange Rate Adjustments	-26.31M	159M	18.55M	1.74M	-18.64M
Net Change in Cash	446M	-422M	-63.76M	-289M	459M
Supplemental Items
Cash Interest Paid	959K	2.68M	2.17M	1.61M	3.14M
Cash Income Tax Paid (Refund)	-	-	-	78.69M	32.25M
Levered Free Cash Flow	-45.64M	-196M	-268M	73.63M	100M
Unlevered Free Cash Flow	-45.04M	-194M	-267M	74.64M	102M
Change In Net Working Capital	-40.98M	-13.25M	654K	-51.22M	-35.58M
Net Debt Issued / Repaid	-7.41M	-8.64M	-9.44M	-9.46M	281M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-12.36	-12.08	-13.87	-0.64	0.78
Return on Total Capital	-12.79	-12.48	-14.49	-0.67	0.83
Return On Equity %	-252.96	-20.3	-19.95	1.44	2.85
Return on Common Equity	-252.96	-20.3	-19.95	1.44	2.85
Margin Analysis
Gross Profit Margin %	100	-	100	100	100
SG&A Margin	550.11	-	505.78	14.72	12.38
EBITDA Margin %	-1.43K	-	-2.65K	-2.14	6.28
EBITA Margin %	-1.44K	-	-2.68K	-4.28	4.56
EBIT Margin %	-1.45K	-	-2.68K	-4.28	4.56
Income From Continuing Operations Margin %	-7.98K	-	-2.26K	5.62	9.03
Net Income Margin %	-7.98K	-	-2.26K	5.62	9.03
Net Avail. For Common Margin %	-7.98K	-	-2.26K	5.62	9.03
Normalized Net Income Margin	-803.43	-	-1.42K	9.68	11.68
Levered Free Cash Flow Margin	-201.23	-	-1.41K	14.61	16.39
Unlevered Free Cash Flow Margin	-198.59	-	-1.4K	14.81	16.73
Asset Turnover
Asset Turnover	0.01	-	0.01	0.24	0.27
Fixed Assets Turnover	0.54	-	0.26	8.25	14.38
Short Term Liquidity
Current Ratio	35.1	22.39	18.7	14.92	4.98
Quick Ratio	34.98	22.19	18.42	14.82	4.95
Operating Cash Flow to Current Liabilities	-2.31	-3.2	-4.07	-0.1	0.19
Long Term Solvency
Total Debt/Equity	2.12	1.94	1.8	1.24	15.78
Total Debt / Total Capital	2.08	1.91	1.77	1.22	13.63
LT Debt/Equity	1.77	1.52	1.27	0.68	0.16
Long-Term Debt / Total Capital	1.74	1.49	1.25	0.67	0.14
Total Liabilities / Total Assets	4.46	5.75	6.35	7.06	18.28
EBIT / Interest Expense	-342.25	-185.17	-235.52	-13.43	8.37
EBITDA / Interest Expense	-329.86	-179.91	-228.25	-0.72	14.23
(EBITDA - Capex) / Interest Expense	-339.26	-187.22	-232.68	-3.25	13.22
Total Debt / EBITDA	-0.17	-0.09	-0.07	-21.03	6.4
Net Debt / EBITDA	7.96	4.83	3.99	1.72K	-37.86
Total Debt / (EBITDA - Capex)	-0.17	-0.09	-0.07	-4.65	6.89
Net Debt / (EBITDA - Capex)	7.74	4.64	3.91	379.67	-40.76
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	-	-	2.54K	21.45
Gross Profit, 1 Yr. Growth %	-	-	-	2.54K	21.45
EBITDA, 1 Yr. Growth %	115.25	52.02	2.46	-97.86	-456.07
EBITA, 1 Yr. Growth %	113.1	51.48	2.79	-95.77	-229.22
EBIT, 1 Yr. Growth %	113.36	51.48	2.79	-95.77	-229.22
Earnings From Cont. Operations, 1 Yr. Growth %	156.14	-72.62	-12.92	-106.56	95.21
Net Income, 1 Yr. Growth %	156.14	-72.62	-12.92	-106.56	95.21
Normalized Net Income, 1 Yr. Growth %	112.49	73.49	-12.78	-118.05	45.37
Diluted EPS Before Extra, 1 Yr. Growth %	8.17	-89.64	-16.49	-105.97	121.11
Net Property, Plant and Equip., 1 Yr. Growth %	368.99	11.55	-10.29	-23.83	-38.81
Total Assets, 1 Yr. Growth %	298.6	-6.22	-15.03	-0.39	11.68
Tangible Book Value, 1 Yr. Growth %	-329.14	-7.55	-15.6	-1.16	-1.78
Common Equity, 1 Yr. Growth %	-329.51	-7.48	-15.57	-1.15	-1.81
Cash From Operations, 1 Yr. Growth %	38.17	102.6	29.32	-97.09	-713.48
Capital Expenditures, 1 Yr. Growth %	160.37	117.64	-51.05	-57.63	-17.08
Levered Free Cash Flow, 1 Yr. Growth %	-43.83	329.41	36.67	-126.75	295.33
Unlevered Free Cash Flow, 1 Yr. Growth %	-44.42	331.4	37.15	-127.25	288.17
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	143.13	-	-8.33	-	466.7
Gross Profit, 2 Yr. CAGR %	143.13	-	-8.33	-	466.7
EBITDA, 2 Yr. CAGR %	83.14	81.09	24.81	-85.2	-72.41
EBITA, 2 Yr. CAGR %	81.42	79.86	24.78	-79.16	-76.63
EBIT, 2 Yr. CAGR %	81.61	79.78	24.78	-79.16	-76.63
Earnings From Cont. Operations, 2 Yr. CAGR %	267.64	-16.25	-51.17	-76.1	-64.22
Net Income, 2 Yr. CAGR %	267.64	-16.25	-51.17	-76.1	-64.22
Normalized Net Income, 2 Yr. CAGR %	47.56	90.05	23.01	-60.32	-48.55
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-66.52	-70.58	-77.62	-63.67
Net Property, Plant and Equip., 2 Yr. CAGR %	85.88	128.73	0.04	-17.34	-31.73
Total Assets, 2 Yr. CAGR %	187.91	93.34	-10.73	-8	5.47
Tangible Book Value, 2 Yr. CAGR %	134.91	45.55	-11.67	-8.67	-1.47
Common Equity, 2 Yr. CAGR %	135.05	45.72	-11.62	-8.64	-1.48
Cash From Operations, 2 Yr. CAGR %	43.16	67.31	61.87	-80.61	-57.78
Capital Expenditures, 2 Yr. CAGR %	61.99	138.05	3.22	-54.46	-40.73
Levered Free Cash Flow, 2 Yr. CAGR %	-	55.31	142.26	-38.71	-39.63
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	54.84	143.24	-38.02	-38.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	181.13	-
Gross Profit, 3 Yr. CAGR %	-	-	-	181.13	-
EBITDA, 3 Yr. CAGR %	-	72.24	49.78	-67.83	-57.27
EBITA, 3 Yr. CAGR %	-	70.96	49.26	-59.63	-61.71
EBIT, 3 Yr. CAGR %	-	70.96	49.22	-59.63	-61.71
Earnings From Cont. Operations, 3 Yr. CAGR %	-	54.68	-15.16	-74.99	-51.87
Net Income, 3 Yr. CAGR %	-	54.68	-15.16	-74.99	-51.87
Normalized Net Income, 3 Yr. CAGR %	-	54.68	46.6	-35.12	-38.65
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-54.6	-82.69	-51.98
Net Property, Plant and Equip., 3 Yr. CAGR %	-	56.79	67.43	-8.65	-25.23
Total Assets, 3 Yr. CAGR %	-	98.1	47	-7.41	-1.86
Tangible Book Value, 3 Yr. CAGR %	-	72.15	21.37	-8.3	-6.43
Common Equity, 3 Yr. CAGR %	-	72.26	21.48	-8.26	-6.42
Cash From Operations, 3 Yr. CAGR %	-	60.73	53.55	-57.62	-38.68
Capital Expenditures, 3 Yr. CAGR %	-	78.75	40.51	-23.29	-44.39
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	48.83	17.28	-20
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	48.71	18.33	-19.22
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	-	165.27	-
Gross Profit, 5 Yr. CAGR %	-	-	-	165.27	-
EBITDA, 5 Yr. CAGR %	-	-	-	-35.47	-23.87
EBITA, 5 Yr. CAGR %	-	-	-	-26.33	-28.91
EBIT, 5 Yr. CAGR %	-	-	-	-26.33	-28.92
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	-	-26.72	-39.94
Net Income, 5 Yr. CAGR %	-	-	-	-26.72	-39.94
Normalized Net Income, 5 Yr. CAGR %	-	-	-	-10.24	-3.57
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	-	-	-58.43
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	21.37	16.95
Total Assets, 5 Yr. CAGR %	-	-	-	45.76	28.72
Tangible Book Value, 5 Yr. CAGR %	-	-	-	33.6	11.66
Common Equity, 5 Yr. CAGR %	-	-	-	33.66	11.72
Cash From Operations, 5 Yr. CAGR %	-	-	-	-31.03	-8.39
Capital Expenditures, 5 Yr. CAGR %	-	-	-	3.45	-0.51
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	4.31
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	4.79